BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200915T083000
DTEND;TZID=Europe/London:20200915T093000
DTSTAMP:20260403T220448
CREATED:20200827T153500Z
LAST-MODIFIED:20200827T153500Z
UID:18345-1600158600-1600162200@www.medilinkmidlands.com
SUMMARY:Medilink East Midlands Virtual Coffee Break - Members Only
DESCRIPTION:Join Medilink EM for an early morning virtual coffee break on Tuesday 15 September at 8.30am. \nNetworking opportunities are one of the many Medilink EM member benefits and whilst the current COVID-19 crisis still won’t allow face to face events\, we have introduced an online opportunity to enable members to still connect with one another. This is an informal gathering\, hosted by Darren Clark\, our Chief Executive\, where you can share your current challenges and experiences and we can make introductions to those that can help. Or you could also join us just to see a friendly face and take time out from working at home. \nThe theme of today’s coffee break will be ‘How has your marketing changed?’ \nGrab a coffee and join us. \nDial-in details will provided to delegates by a member of the Medlink EM events team once the online registration form has been completed. \nMedilink Members only \n 
URL:https://www.medilinkmidlands.com/event/medilink-east-midlands-virtual-coffee-break-members-only/
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200915T140000
DTEND;TZID=Europe/London:20200915T150000
DTSTAMP:20260403T220448
CREATED:20200810T091214Z
LAST-MODIFIED:20200810T091214Z
UID:18313-1600178400-1600182000@www.medilinkmidlands.com
SUMMARY:The Killer Issue: How to mitigate risk when designing in-vivo devices
DESCRIPTION:SEHTA & eg technology  \nSeries of In-vivo devices\, Microfluidics and Diagnostics Webinars \nSeptember 2020 \nSEHTA and eg technology are delighted to announce a series of webinars on the topics of In-vivo devices\, Microfluidics and Diagnostics to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 1 hour:  14:00 – 15:00 (UK time) \nThese webinars will be run via WEBEX – details on application \nRisk goes hand in hand with medical device design and development – intervening in the human body will always have the potential to go wrong. But what happens when device limitations could result in serious injury or even death? Join egt director\, Danny Godfrey as he looks specifically at the design and development of in-vivo devices and how risks are identified\, managed\, and mitigated to minimize the risk of potentially catastrophic outcomes. \nStarting with a brief overview of the medical device development process\, this webinar will address the importance of examining the full use cycle of your device and identifying risks early on in your project – including less obvious and sometimes unseen obstacles – whilst ensuring full traceability throughout. \nTopics to be covered include: \n\nThe key things to consider from the outset of any development programme\nHow to identify the full spectrum of potential risks \nWhen in your programme this should happen\nThe importance of device classification and mapping risks against standards\nHow to mitigate risks to allow you to get on with your design\n\nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \nEarly bird rate – book by 31st August 2020 \n£55 + VAT pp per webinar for members / £65 + VAT non-members \nAfter 31st August 2020 \n£65 +VAT pp per webinar for members / £75 + VAT non members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nFor more information and to book\, click here
URL:https://www.medilinkmidlands.com/event/the-killer-issue-how-to-mitigate-risk-when-designing-in-vivo-devices/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200916T130000
DTEND;TZID=Europe/London:20200916T143000
DTSTAMP:20260403T220448
CREATED:20200626T134819Z
LAST-MODIFIED:20200626T134819Z
UID:18244-1600261200-1600266600@www.medilinkmidlands.com
SUMMARY:Webinar: Life Sciences Opportunities in Wallonia\, Belgium
DESCRIPTION:Wallonia\, the French-speaking region of Belgium\, is one of the key references in the field of life sciences\, as it occupies a pivotal role for the European and global pharmaceutical industry thanks to a unique ecosystem. The ongoing efforts to improve the business environment in the region have allowed companies to improve their competitiveness through lower costs and easier access to facilities and qualified workforce. This is why the region has been chosen to produce the active substance for the AstraZeneca vaccine against covid-19. \nIf your company wishes to learn about Wallonia’s unique advantages and is thinking about expanding to Mainland Europe\, you are welcome to attend this webinar. AWEX\, the Walloon Agency in charge of Foreign Trade and Investment\, will present the region’s ecosystem. \nThe webinar will cover:\n– The Walloon ecosystem for the life sciences industry\n– The Biowin Cluster\n– The 6 strategic domains: (bio)pharmacy\, cell therapy\, radiation applied to health\, medical devices and in vitro diagnostics\, biomanufacturing\, data science\n– The Science Parks Network\n– The 2 potential partners: BioPark Charleroi & Louvain la Neuve Science Park \n-The Belgian tax regime \n-Tax incentives for R&D & IP in Belgium \n-Financial incentives \n– Cash grants \n-Subsidies for foreign companies \n-Welcome office \nThere will also be the opportunity to ask questions directly to the speakers. \nTO BOOK YOUR PLACE\, PLEASE CLICK HERE\nSpeaker Profiles: \nMaxime Couvreur\, Trade & Investment Counsellor\, The Embassy of Belgium – AWEX \n  \n  \n  \n  \nLaurence Slangen\, Business Relations Manager\, SPI Agency (Liège Region)/Representative of the SpoW (Science Parks of Wallonia) Network \n  \n  \n  \nMarc Dechamps\, Director of International Affairs\, Biowin Cluster\, Wallonia \n  \n  \n  \n \nNicolas Honhon\, Tax Expert & Brexit Expert – Fiscal Department\, Foreign Investment of the Federal Public Service of Belgium. (based in the Belgium Embassy in London) \n  \n  \n  \n  Régis César\, Scientific advisor\, department of research & innovation\, Walloon administration \n  \n 
URL:https://www.medilinkmidlands.com/event/webinar-life-sciences-opportunities-in-wallonia-belgium/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Maxime-Couvreur.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200916T140000
DTEND;TZID=Europe/London:20200916T150000
DTSTAMP:20260403T220448
CREATED:20200810T091604Z
LAST-MODIFIED:20200810T091604Z
UID:18314-1600264800-1600268400@www.medilinkmidlands.com
SUMMARY:Microfluidics; small technology\, big pitfalls
DESCRIPTION:Series of In-vivo devices\, Microfluidics and Diagnostics Webinars \nSeptember 2020 \nSEHTA and eg technology are delighted to announce a series of webinars on the topics of In-vivo devices\, Microfluidics and Diagnostics to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 1 hour:  14:00 – 15:00 (UK time) \nThese webinars will be run via WEBEX – details on application \nIt is estimated that the Global Microfluidics Market will have a value of over USD 53 billion by the end of 2027\, but how much do you really know about Microfluidics and how it fits in to a design programme? \nThis webinar will look at the various development challenges when working with Microfluidics. Starting with an overview of applications and fabrication technologies\, we will then discuss the relationship between single use consumables and multi-use products with examples\, the different fluid handling technologies and then move on to the main developmental obstacle; identifying\, assessing and overcoming the many pitfalls associated with Microfluidics. \nThis webinar will cover: \n\nAn overview of Microfluidics and how it is incorporated into development programmes\nUnderstanding the different technologies available and identifying the most suitable option for your programme\nThe importance of identifying and assessing risks early in your programme and overcoming these development challenges\n\nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \nEarly bird rate – book by 31st August 2020 \n£55 + VAT pp per webinar for members / £65 + VAT non-members \nAfter 31st August 2020 \n£65 +VAT pp per webinar for members / £75 + VAT non members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nFor more details and to book\, click here
URL:https://www.medilinkmidlands.com/event/microfluidics-small-technology-big-pitfalls/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200917T103000
DTEND;TZID=Europe/London:20200917T120000
DTSTAMP:20260403T220448
CREATED:20200806T073511Z
LAST-MODIFIED:20200806T073511Z
UID:18304-1600338600-1600344000@www.medilinkmidlands.com
SUMMARY:WEBINAR: Infectious Diseases Special Interest Group (SIG) - Infection Control during COVID-19: Masks\, hands and surfaces
DESCRIPTION:The next Infectious Diseases Special Interest Group will take place online and the focus will be on Infection Control during COVID-19: Masks\, hands and surfaces. \nThis event is in partnership with De Montfort University and led by Dr Katie Laird\, Reader in Microbiology and also Head of the Infectious Disease Research Group at De Montfort University. Presentations will be given on: \n– Masking the masses: Efficacy and controversies of face masks\n– Surface Disinfection\, hand sanitation and COVID-19.  What have we done\, and what should we have done?\n– Supporting the NHS during COVID-19 \nDURATION: 1.5 hours \nThis free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n\nDr Katie Laird\, Head of the Infectious Disease Research Group at Leicester School of Pharmacy\, De Montfort University \nKatie has a BSc (Hons) in Biology and obtained a PhD in applied microbiology in 2008. During her PhD she developed and patented an essential oil based antimicrobial vapour\, whilst her postdoctoral work included the assessment of natural antimicrobials efficacy against post-harvest pathogens.\nHer research interests include the use of natural products as antimicrobials in particular to combat hospital acquired infections and biofilms.  Her other area of research includes the assessment of healthcare laundry as a potential route of cross contamination in the clinical arena. \n \nDr Maitreyi Shivkumar\, Lecturer in Molecular Biology at Leicester School of Pharmacy\, De Montfort University\nMaitreyi is a virologist and lecturer in De Montfort University. Her research has focussed on host-pathogen interactions in the context of entry and transmission of viruses. She has recently established her lab at the Leicester School of Pharmacy\, where she is working on developing broad-spectrum antivirals as well as investigating infection control strategies against coronaviruses. \n\nDr Andrew Kemp\, Principal Scientific Officer\, Q Technologies\nAndrew holds a PhD in surface disinfection and decontamination. His specialist area of research is testing for bio burden\, long term disinfection and decontamination. Dr Kemp consults for BICSc\, governments\, private organisations and companies. He is regarded as a global expert in his specialist area of work\, undertaking research at the University of Lincoln and the University of Baltimore. He is a member of the steering group for the UK Infectious Diseases Research group. He recently completed writing the environmental cleaning and disinfection guide and standards for the UK NHS Improvement organisation. \n\nLinda Knight\, Training Specialist\, Pal International\nLinda has worked in medical consumables for over 25 years as a business development manger and specialist trainer primarily in the infection prevention sphere. Linda currently works for Pal International in the MediPal division. She has a keen interest in cooking having trained as a chef and loves to spend time with her grandchildren.
URL:https://www.medilinkmidlands.com/event/webinar-infectious-diseases-special-interest-group-sig-infection-control-during-covid-19-masks-hands-and-surfaces/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Katie-Laird.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200917T140000
DTEND;TZID=Europe/London:20200917T150000
DTSTAMP:20260403T220448
CREATED:20200810T091846Z
LAST-MODIFIED:20200810T091846Z
UID:18315-1600351200-1600354800@www.medilinkmidlands.com
SUMMARY:Diagnosing the risk in diagnostics development; man versus machine
DESCRIPTION:Series of In-vivo devices\, Microfluidics and Diagnostics Webinars \nSeptember 2020 \nSEHTA and eg technology are delighted to announce a series of webinars on the topics of In-vivo devices\, Microfluidics and Diagnostics to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 1 hour:  14:00 – 15:00 (UK time) \nThese webinars will be run via WEBEX – details on application \nThe design and development of Diagnostic devices within the medical industry is a complex process\, fraught with usability uncertainties. Many clinicians are reluctant to make a diagnosis without the confirmation of a device\, but devices cannot always be used in isolation as they do not have the full picture and patient knowledge of the clinician. This dichotomy makes the development of such devices often difficult. So\, how do we develop a diagnostics device which satisfies the product\, patient\, and clinician requirement specifications? Furthermore\, how can we develop a diagnostics strategy that addresses the codependence of diagnostic devices and their user? \nThis webinar will focus on what it takes to produce a diagnostics device which not only meets requirements but lives up to its marketing. Looking at the user and usability requirements\, how your device should be classified and the importance of creating a defined strategy\, we will discuss the human factors involved with diagnostics design and how total reliance on the device is not always the best option.  \nTopics to be covered include: \n\nThe key considerations in a diagnostics device development programme\nThe importance of identifying your product strategy early in your programme\nHow to keep usability and the end-user in mind throughout\nNavigating the regulatory process\nClosing the design loop – ensuring your end product does what you say it does!\n\nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \nEarly bird rate – book by 31st August 2020 \n£55 + VAT pp per webinar for members / £65 + VAT non-members \nAfter 31st August 2020 \n£65 +VAT pp per webinar for members / £75 + VAT non members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nFor more details\, and to book your place\, click here
URL:https://www.medilinkmidlands.com/event/diagnosing-the-risk-in-diagnostics-development-man-versus-machine/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200922T103000
DTEND;TZID=Europe/London:20200922T113000
DTSTAMP:20260403T220448
CREATED:20200818T151840Z
LAST-MODIFIED:20200818T151840Z
UID:18333-1600770600-1600774200@www.medilinkmidlands.com
SUMMARY:Webinar: Is your Business Case NHS Ready?
DESCRIPTION:Join the second of our two-part CPD accredited virtual workshops\, Is your Business Case NHS Ready?\, delivered by the East Midlands Academic Health Science Network (EMAHSN). \nThe challenge as innovators and companies selling to the NHS is often that when you have a product that improves patient outcomes and saves cost you still cannot get it adopted by the NHS. This is frequently because there isn’t a fully developed business case. \nPART 1 is a pre-recorded 40 minute webinar that you can watch at a time convenient to you. \nThe webinar will cover: \n– What a business case is\, what is its purpose and why is it so important? \n– Who reviews the business case and how are they evaluated? \n– How to construct a good business case \n—————— \nPART 2 is a live 1-hour Q&A session that will take place on Tuesday 22nd September. \nIn order to gain access to this live session\, delegates are required to watch the pre-recorded webinar prior to attending.  \nThe Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team. \nUpon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink East Midlands events team.  Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.  \nSPEAKER PROFILE: \n Nicholas Brown\, Commercial Manager\, East Midlands Academic Health Science Network \nNick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this\, Nick has more than 20 years’ experience of the medical industry working with manufacturers\, distributors and clinical staff from the UK and European health sectors\, from both the sales and marketing side\, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region – as well as marketed throughout the UK and abroad\, providing wealth creation opportunities across the East Midlands.
URL:https://www.medilinkmidlands.com/event/webinar-is-your-business-case-nhs-ready/
ATTACH;FMTTYPE=image/png:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Badge-for-EMAHSN-Webinars.png
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200923T110000
DTEND;TZID=Europe/London:20200923T120000
DTSTAMP:20260403T220448
CREATED:20200212T133227Z
LAST-MODIFIED:20200212T133227Z
UID:18064-1600858800-1600862400@www.medilinkmidlands.com
SUMMARY:Webinar: Precision Imaging- transforming healthcare and nutrition with pioneering imaging
DESCRIPTION:Join this webinar with the University of Nottingham where they will showcase the latest developments and capabilities in precision imaging. \nTopics will include innovations in the application of imaging tools to:\n-Pharmaceuticals\n-Nutrition in food and beverages\n-Medical Devices\n-Biomarkers for health \nThere will also be an opportunity to ask your questions directly to the presenters in a Q&A session. \nA wide range of available expertise will be explored from medicine\, physics\, mathematics\, psychology\, life sciences and computer sciences. Information will also be presented on the facilities dedicated to research full time\, so you can find facilities and expertise to help with your product development. \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \nProfessor Dorothee Auer\, Professor of Neuroimaging\, MD\, PhD  \nDirector\, Precision Imaging Beacon of Excellence\, Imaging Theme Lead\, NIHR ~Nottingham BRC \nDorothee’s research interest is to develop imaging biomarkers in Clinical Neurosciences using advanced MRI techniques. Aims are: (1)understand the pathophysiology of diseases/complex symptoms across diseases\, (2)improve diagnostic accuracy\, (3)predict and assess therapeutic interventions. Methods include MR proton spectroscopy\, diffusion tensor imaging\, perfusion\, relaxometry\, high resolution carotid imaging and combined electrophysiological/fMRI. \nProfessor Luca Marciani\, Precision Imaging Beacon\, Industrial Strategy and Business Engagement Lead\, University of Nottingham \nLuca’s expertise is in imaging the human gastrointestinal (GI) tract using MRI. His research focuses on GI physiology/pathology using MRI combined with other techniques. Luca is interested in in-body imaging of foods\, beverages\, dosage forms and formulations\, intestinal fluid distribution and developing novel MRI tests for GI motility and transit. \n  \n 
URL:https://www.medilinkmidlands.com/event/precision-imaging-transforming-healthcare-and-nutrition-with-pioneering-imaging/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Dorothee-Auer.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200924T103000
DTEND;TZID=Europe/London:20200924T120000
DTSTAMP:20260403T220448
CREATED:20200819T071659Z
LAST-MODIFIED:20200819T071659Z
UID:18317-1600943400-1600948800@www.medilinkmidlands.com
SUMMARY:WEBINAR: AI and Smart-Tech in the Home
DESCRIPTION:This webinar will explore AI and Smart-Tech in the Home\, take the opportunity to hear from Research Associates and Industry on this topic.  This event is in partnership with The Open University Faculty of Wellbeing\, Education and Language Studies. \nThe presenters will cover: \n– The MK:Smart programme\, a smart city initiative update and future directions for the smart city using the example of a hypothetical smart project using robots to encourage people to engage in active travel\, supporting healthy ageing and reducing social isolation \n– Hear from Pantri\, a company who embed AI into home appliances \n– Home assistance robots \n– A brief historical overview of robotic assistants plus overview of ‘Gatekeeper’ project including details on the application and it’s functionalities \nDURATION: 1.5 hours \nThis free to attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles:\n\nGaynor Henry-Edwards\, Research Manager\, Faculty of Wellbeing\, Education and Language Studies – The Open University \nGaynor manages the Health and Wellbeing Strategic Research Area at The Open University. The Strategic Research Area supports\, coordinates and promotes health and wellbeing research across the university. Open University researchers conduct research in health and wellbeing across various disciplines and areas including healthcare management\, ageing studies\, reproductive and sexual rights\, assistive technologies\, patient data management\, mental health and biological health sciences. The scope of University expertise ranges from the science underpinning health and disease through to the medical humanities. The Open University is committed to working towards social justice specialising in participative and inclusive research methods with marginalised and vulnerable communities. \n\nMiguel Valdez\, Lecturer in Technology and Innovation Management\, School of Engineering and Innovation – The Open University\nMiguel began his career as a software engineer\, went on to become a technology journalist and is currently working as a Research Associate in the School of Engineering and Innovation at the Open University. His doctoral research interrogated sustainable transport pilots in Milton Keynes\, with a particular focus on the sensemaking activities that took place in organisations. He further developed this understanding of cities as experimental spaces within the transport work package of MK:Smart\, a £16 million smart city programme. Through his research\, Miguel has explored the role of innovative technologies in envisioned and developing future urban environments. His research has drawn insights from urban geography and innovation studies to interrogate how the experimental spaces in cities may facilitate the development of new knowledge about sustainable innovation\, and on how such knowledge coalesce and travel. \n\nTom Cooper\, CEO\, Pantri\nTom is the CEO and founder of Pantri – a new platform which aims to make the new breed of WiFi connected kitchen appliances shop for repeat purchases automatically.  He is considered a thought leader in the smart kitchen industry\, with regular appearances in industry publications where he shares his views on how over the next 10 years\, a lot of the weekly shop is going to become a lot easier and automated thanks to exciting new IoT and AI breakthroughs. \n\nGianluca Bardaro\, Research Associate\, Knowledge Media Institute – The Open University \nGianluca’s area of research is robotic software development. In particular\, he is interested in how to enhance the existing tools and approaches to streamline the development process and achieve more complex\, robust and functionality-rich robot applications. Currently\, he is involved in the GATEKEEPER European project\, as a task leader. As part of this project\, his aim is developing a robotic assistant which operates within a smart home environment and which is capable of addressing the healthcare needs of elderly people.
URL:https://www.medilinkmidlands.com/event/webinar-ai-and-smart-tech-in-the-home/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/GaynorHenryEdwards_OU.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200928
DTEND;VALUE=DATE:20200929
DTSTAMP:20260403T220448
CREATED:20190923T123050Z
LAST-MODIFIED:20190923T123050Z
UID:18015-1601251200-1601337599@www.medilinkmidlands.com
SUMMARY:SEHTA's 1st International MedTech Expo & Conference
DESCRIPTION:The SME focused healthcare event for driving collaborations between Business\, Care & Clinicians & Academics \nSEHTA’s 1st International MedTech Expo & Conference \nDevices\, Diagnostics\, Digital\nAt one EVENT & in one DAY \nOver the last 15 years\, South East Health Technologies Alliance (SEHTA) has developed an excellent reputation for support of its 1\,300 members\, especially SMEs\, through its one to one mentoring\, fund-finding\, consultancy and events programme. \nIn 2020\, for the first time\, SEHTA is organising a major new international event in London designed to take the programme of support to another level. \nWe cordially invite you to join us on Thursday 26th March 2020 for SEHTA’s first International MedTech Expo & Conference taking place at the Hilton London Tower Bridge. This event is aimed at SME’s\, Corporates\, Academics & NHS Healthcare Providers. \nThe conference and expo aims to help delegates: \nUnderstand: Make sense of the complexities of healthcare support and challenges of accessing the NHS \nFind: Funding opportunities (public sector\, private\, NHS) \nNavigate: Regulatory\, legal and IP issues \nIdentify: Current clinical challenges in the NHS \nAnd perhaps most of all…. Make new contacts leading to collaborative partnerships at the event and through our bespoke 1:1 partnering website\n(available from January 2020 to book your meetings) \nFor further information\, please click here to email SEHTA.
URL:https://www.medilinkmidlands.com/event/sehtas-1st-international-medtech-expo-conference/
LOCATION:Hilton London Tower Bridge\, 5 More London Riverside\, London\, SE1 2BY
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200929T130000
DTEND;TZID=Europe/London:20200929T140000
DTSTAMP:20260403T220448
CREATED:20200907T110101Z
LAST-MODIFIED:20200907T110101Z
UID:18364-1601384400-1601388000@www.medilinkmidlands.com
SUMMARY:Medilink East Midlands Virtual Coffee Break - Members Only
DESCRIPTION:Join Medilink EM for an afternoon virtual coffee break on Tuesday 29 September at 1.00pm. \nNetworking opportunities are one of the many Medilink EM member benefits and whilst the current COVID-19 crisis still won’t allow face to face events\, we have introduced an online opportunity to enable members to still connect with one another. This is an informal gathering\, hosted by Darren Clark\, our Chief Executive\, where you can share your current challenges and experiences and we can make introductions to those that can help. Or you could also join us just to see a friendly face and take time out from working at home. \nThis virtual coffee break will provide the opportunity to hear an update on our recent activity\, in particular plans for Medilink Midlands. \nGrab a coffee\, a biscuit and join us. \nDial-in details will provided to delegates by a member of the Medlink EM events team once the online registration form has been completed. \nMedilink Members only
URL:https://www.medilinkmidlands.com/event/medilink-east-midlands-virtual-coffee-break-members-only-2/
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200930T110000
DTEND;TZID=Europe/London:20200930T120000
DTSTAMP:20260403T220448
CREATED:20200902T133927Z
LAST-MODIFIED:20200902T133927Z
UID:18346-1601463600-1601467200@www.medilinkmidlands.com
SUMMARY:WEBINAR: Clinical Trial - Design or Disaster?
DESCRIPTION:Join this ‘Clinical Trial – Design or Disaster?’ webinar to hear from Afortori Development and Simplified Data. This one hour webinar will explore: \n– Why is diligent and robust trial design needed?\n– What does it need to prove?\n– How complex does it need to be?\n– What kind of analysis needs to be undertaken? \nAttend to learn about the above and take the opportunity to get your questions answered by the experts. \nDURATION: 1 hour \nThis free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles:\n\nDanielle Bodicoat\, Medical Statistics & Writing Consultant\, Simplified Data\nDanielle has over 12 years of experience as a medical statistician and writer with extensive experience of designing\, conducting and analysing clinical trials. She began her career researching the causes of breast cancer at the Institute of Cancer Research (University of London). She then went on to be a researcher and lecturer at the University of Leicester\, with a focus on diabetes. After a period working at Walgreens Boots Alliance to gain industry experience\, Danielle set up Simplified Data in 2019.  Danielle has a wealth of research\, statistics and writing experience. Danielle has particular expertise in diabetes and cardiovascular disease trials. Danielle has a PhD in Epidemiology\, MSc in Medical Statistics (Distinction) and BSc in Mathematics with Statistics (1st Class). \nNicola Wall \, along with Elizabeth Ralph founded Afortiori Development after long careers in clinical research within a variety of roles. Both bring a commitment to well designed and successfully executed clinical trials. \n\nDr Nicola Wall\, Chief Executive Officer\, Afortori Development  \n\nElizabeth Ralph\, Chief Operating Officer\, Afortori Development \n\nCharlotte Culver\, Clinical Project Leader\, Afortori Development\nCharlotte has a strong project management background in clinical research Phases I-V while delivering both commercial and non-commercial research throughout her career to produce quality results.\nShe is experienced in both pharmaceutical and device trials across several disease areas throughout the lifecycle of the project\, in collaboration with key pharmaceutical and device companies in the industry.\nHer proven project management track record provides her with the tools to deliver excellence and detailed delivery in clinical\, regulatory\, and financial aspects of clinical research.\nThroughout her research career\, she has worked on projects internationally\, as either multicentered or single-centre as lead. \n 
URL:https://www.medilinkmidlands.com/event/webinar-clinical-trial-design-or-disaster/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Danielle-Bodicoat.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201001T100000
DTEND;TZID=Europe/London:20201001T110000
DTSTAMP:20260403T220448
CREATED:20200923T090623Z
LAST-MODIFIED:20200923T090623Z
UID:18378-1601546400-1601550000@www.medilinkmidlands.com
SUMMARY:WEBINAR: Manufacturing Face Masks and PPE - what you need to know
DESCRIPTION:SGS Webinar demystifies face mask and PPE Certification for manufacturers \nSGS’s webinar\, in association with Medilink Midlands\, will explain in simple terms the steps that manufacturers must take to place personal protective equipment (PPE) and face masks on the market. \nThe pandemic has led to exponential growth in PPE demand\, with the market now projected to reach $85.72 billion (£67.87 billion) by 2026 according to Fortune Business Insights – a compound annual growth rate of 7.3%. \nTo take advantage of this lucrative market\, many companies are pivoting to include PPE manufacturing in their products and services or expanding into new geographies\, such as overseas manufacturers entering the UK market. Lancashire Textiles\, for example\, has switched from producing duvets\, blankets\, and towels to manufacturing face masks. 3D Folkes has been supplying NHS workers with 3D printed face shields. \nHowever\, new entrants to the market are finding themselves caught in a maze of requirements to have products certified to sell in the UK as PPE. These processes can be easily misunderstood – especially among the confusion and noise that the pandemic has created. \nTo help manufacturers understand the different types of PPE\, and the testing and certification process\, SGS experts Kevin Foy and Kelvin Shepherd will cover everything you need to know about getting your products placed on the market. \nAt the end of this one-hour session\, attendees will have the opportunity to pose their questions. As part of a global network of PPE experts and accredited laboratories\, both Kevin and Kelvin are well placed to advise on how you can ensure the compliance of your face masks and PPE products. \nThis webinar will help you to understand the steps you need to take and the timeframes involved to get your goods to market. \nTo find out more and to book your free place\, please click here. 
URL:https://www.medilinkmidlands.com/event/webinar-manufacturing-face-masks-and-ppe-what-you-need-to-know/
CATEGORIES:Medilink Partner Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Medilink-Midlands-Logo-orange-final.jpg
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201001T100000
DTEND;TZID=Europe/London:20201001T113000
DTSTAMP:20260403T220448
CREATED:20200327T100140Z
LAST-MODIFIED:20200327T100140Z
UID:18108-1601546400-1601551800@www.medilinkmidlands.com
SUMMARY:Webinar: Commercial Applications for Next Generation Biomaterials
DESCRIPTION:This webinar with the University of Nottingham will look at Commercial Applications for Next Generation Biomaterials. \nThe biomaterials discovery programme at the University of Nottingham has been targeting novel polymers with application as coatings for existing medical devices to reduce infection rates and controlling foreign body reaction\, cell culture consumables for expansion and differentiation of stem cells\, particulates for targeting therapeutic delivery for cancer and infections and surfaces to control viral\, fungal and bacterial attachment in a wide variety of industries. They are looking for industrial organisations to partner with in the exploitation of these materials. \nPresentations will include: \n– Controlling bacterial biofilms formation using polymers \n– Controlling foreign body reaction to medical implants using coatings \n– New materials for breast cancer therapies \n– Technologies to control Fibrosis \nThere will be a Q&A session during the webinar. We have also created a facility post event (11.30am – 12.00pm) for you to join the presenters in a Microsoft Teams meeting to ask further questions directly to the presenters. Details of this meeting will be shared during the webinar. \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nThe Biomaterials Discovery project at the University of Nottingham has funding available to partner with industrial partners that are keen to explore its emerging novel biomaterials and their potential in healthcare in short proof of concept studies. They encourage any companies that can see application of these technologies in their area to contact the panellists in the discussion session or send us an email. Please click here to contact the team. \n  \nSPEAKER PROFILES: \n \nProfessor Morgan Alexander\, Professor of Biomedical Surfaces\, University of Nottingham \nMorgan Alexander is Professor of Biomedical Surfaces\, the Director of the EPSRC Programme Grant in Next Generation Biomaterials Discovery and a Wellcome Trust Senior Investigator based in the School of Pharmacy at the University of Nottingham. He received his BSc in Materials (1988) and his PhD from the same department at The University of Sheffield in 1992. \nHis work involves developing materials for application in human healthcare and characterising relationships between surface structure and biological properties. Understanding these relationships is critical to the development of next generation biomaterials and it is the theme running through his group’s work across a variety of areas spanning control of bacterial adhesion\, to engineering cell response with applications in medical devices and cell manufacture. \n \nKiril Kalenderski\, PhD Student\, University of Nottingham \nKiril is a researcher at the University of Nottingham\, studying biofilm formation on bio-material surfaces developed as medical device coatings. He has predominantly worked with indwelling urinary catheters\, to determine the efficacy of bio-material coatings in reducing biofilm formation on these devices\, within in vitro experiments and clinical settings. \n  \n  \nDr Robert Cavanagh\, Research Fellow\, University of Nottingham \nRob completed his PhD in Drug delivery in 2017 at the University of Nottingham and focused on investigating intestinal permeability enhancers for the delivery of biologics. He joined Professor Cameron Alexander’s group in December 2017 as a post-doctoral researcher studying chemotherapeutic delivery using novel polymeric nanoparticles. \n  \n  \nDr Patrícia Monteiro\, Research Fellow\, University of Nottingham \nPatrícia received a B.Sc. and M.Sc. in Pharmacy and Pharmaceutical Sciences from the Federal University of Ouro Preto (UFOP)\, Brazil. In 2019 she completed her Ph.D. in drug delivery at the University of Nottingham. She then joined the EPSRC Programme Grant in Next Generation Biomaterials Discovery as a post-doctoral researcher. Her current research is focused on the development of bioresponsive polymers for triple negative breast cancer therapy. \n  \n  \n  \nDr Leanne Fisher\, Research Fellow\, University of Nottingham \nSchool of Life Sciences\, Immunology and Immuno-bioengineering Group \nLeanne’s research has focussed on the design and development of antimicrobial/anti-fouling surfaces to prevent the formation of biofilms on medical devices. More recently\, she has been studying the impact of surface engineering on immune modulation and prevention of the foreign body response. Alongside this\, Leanne works in developing immune-competent biomimetic tissue models\, specifically organ-on-a-chip models. \n  \n \nDr Matthew Vassey\, Research Fellow\, University of Nottingham \nMatthew received a B.Sc. in Microbiology and Cellular Biology in 2005 at the University of Nottingham. In 2014 he completed his Ph.D. in Cellular Microbiology also at the University of Nottingham. He joined the EPSRC Programme Grant in Next Generation Biomaterials Discovery as a post-doctoral researcher in November 2017. His current research is focused on cell biology\, human iPSC derived cells\, 3D biology\, host-pathogen interactions and infection biology. \n  \n  \n \nArsalan Latif\, PhD Student\, University of Nottingham \nArsalan is a final year doctoral student researching in developing stromal instructive niches to promote healing and suppress fibrosis\, at the University of Nottingham. Before which he did his master’s in biomedical engineering at Chalmers University of Technology\, Sweden. Besides science\, he enjoys building Lego models in his spare time. \n 
URL:https://www.medilinkmidlands.com/event/commercial-applications-for-next-generation-biomaterials/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Morgan-Alexander.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201005T080000
DTEND;TZID=Europe/London:20201005T170000
DTSTAMP:20260403T220448
CREATED:20201005T104654Z
LAST-MODIFIED:20201005T104654Z
UID:18383-1601884800-1601917200@www.medilinkmidlands.com
SUMMARY:SEHTA & eg Technology Series of Medical Devices Product Design & Development Webinars November 2020
DESCRIPTION:SEHTA and eg Technology are delighted to be running a second series of Medical Devices Product Design & Development Webinars to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 45 mins max at 14:00 – 14:45 (BST) \nThese webinars will be run via WEBEX – details on application \nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \n£50 +VAT pp per webinar for SEHTA Members \n£60 +VAT pp per webinar for Non-members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nBelow is a list of all available webinars with dates – you can choose as many webinars as you wish to take part in. \n\n\n\nWebinar\nSession Title\nDate\n\n\n1\nNew Product Development – First things First \n  \nWhether you are a first-time entrepreneur or part of a large medical company\, starting a new product development programme can feel like a daunting task. So where should you start? What things do you need to consider at the outset to turn your idea into reality? Starting with an overview of the product development process\, this webinar will move onto the most important\, and often the most overlooked aspect of product development – understanding the user. \n  \nTopics to be covered include: \n  \n·         The key things to consider from the outset of any development programme \n·         The importance of putting the user first \n·         How to obtain useful user insights \n·         How to leverage those insights to make a better product \n \nTuesday 10th November 2020\n\n\n\nFacilitator\nDanny Godfrey\, Co-Founder\, eg Technology \nIn 2002\, Danny and Andrew founded eg technology ltd\, a product design engineering company based in Cambridge UK. They have grown the company organically since then\, and now employ over 30 engineering and commercial staff. \nDanny’s role is to provide corporate leadership\, develop new business opportunities and oversee the technical and strategic direction of projects. He remains involved with the work that eg does\, from the initial proposal writing\, technical & creative input\, design implementation\, review processes and the early identification of development risks. Motivating staff and nurturing client relationships are important aspects of Danny’s day-to-day work – valuing and developing our team of bright\, can-do people and ensuring clients are satisfied with what eg does have been the foundations of success for the company. \nDanny is also a member of the MedTech Accelerator Awards Committee. This organisation supports and finances projects for early-stage companies in the medical sector to create future spin-out companies that aim to bring new life-enhancing technologies to market. \n \n\n\nWebinar\nSession Title\nDate\n\n\n2\nDefining User and Product Specifications During Product Development \n  \nThis webinar will cover what User Requirement Specification (URS) and Product Requirement Specification (PRS) are\, how they differ and how to define them during the product development process. The webinar will end with an interactive quiz. \n  \nTopics to be covered include: \n  \n·         What is a URS and PRS and how do they differ? \n·         What do the standards ask for? \n·         Where do the URS and PRS sit in the product design and development process? \n·         Writing the URS and PRS – best practices \n·         Things to watch out for \n·         Interactive quiz \n \nTuesday 17th November 2020\n\n\nFacilitator\nKella Kapnisi\, Project Manager\, eg Technology \nKella works as part of the project management team. She is responsible for delivering projects from concept through to production\, on time and within budget. Working closely with clients to ensure successful projects across a wide range of products\, including medical devices\, IVDs\, lab equipment & consumer products.  \n  \nKella is also involved in strategic reviews of project operations\, to ensure efficiency in our internal engineering design processes. She led the implementation of the requirement specification process at eg technology\, which forms part of our Quality Management System and she delivered the resultant company-wide training sessions. \n  \nKella has a background in polymer chemistry and a PhD in biomaterial engineering\, under Prof Molly Stevens at Imperial College London\, where she developed tissue engineered cardiac patches for treating heart attacks. Prior to joining eg technology\, Kella was part of a start-up developing implantable heart assist pumps. \n \n\n\n\nWebinar\nSession Title\nDate\n\n\n\n3\nSoftware Design for Medical Devices \n  \nThis webinar will cover Software Design for Medical Devices\, starting with a quick overview to medical device classification\, international standards and the role of IEC 62304. This webinar is intended to look in more detail at some practical applications of the software development processes and what it actually means for the engineers \n  \nTopics to be covered include: \n  \n·         Medical Device Classification & IEC 62304 – a quick refresher \n·         What makes software development different? \no    Software Development \no    Software Testing \no    Software Updates \n·         Structuring software development in practise \no    How to limit the scope of large software projects? \no    Where to draw a boundary around the software components? \no    How to maintain flexibility to update without major retesting/resubmission \no    Software decomposition of safety critical items \n·         Software maintenance considerations \no    What are the regulators worried about? \no    When is a bug not a bug? \n \nTuesday 24th November 2020\n\n\n\nFacilitator\nDavid Warwick\, Director\, eg Technology \nDavid joined eg in 2009 and was appointed as a Director of the company in 2019. As a Director\, he has an overall responsibility for bringing in new business to eg technology and works with the senior management team to constantly evaluate how the business operates to ensure that the company’s strategies support the future growth of eg.  \n  \nDavid’s technical background is in Software Engineering and Electronic Design with over 15 years’ experience in developing medical and IVD device software. During his time at eg technology he has helped numerous clients with the compilation of their technical files and the CE marking and FDA approval of medical devices and IVDs as well as outsourcing final product manufacture. His experience with software development includes extensive experience working with IEC 62304 across all software safety classifications. \n \n\n\n\n For more information on each webinar and to register please click below \n Click Here
URL:https://www.medilinkmidlands.com/event/sehta-eg-technology-series-of-medical-devices-product-design-development-webinars-november-2020/
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201005T133000
DTEND;TZID=Europe/London:20201006T210000
DTSTAMP:20260403T220448
CREATED:20200907T114109Z
LAST-MODIFIED:20200907T114109Z
UID:18365-1601904600-1602018000@www.medilinkmidlands.com
SUMMARY:Mentor Means Business - Conference and Networking
DESCRIPTION:  \n  \n  \n  \n  \n  \nThe Northeast Ohio region is home to some of the leading medical institutions in the United States\, including the Cleveland Clinic\, and the region has developed one of the nation’s most important biomedical clusters. \nOver 700 biomedical firms are located there\, including over 400 medical device manufacturers specializing in imaging\, neuro-stimulation\, orthopaedics\, cardiovascular\, and sterilization.  Among these are world leaders such as General Electric Healthcare\, Siemens\, Toshiba\, Hitachi\, Philips Healthcare\, and STERIS.  STERIS Corporation was founded in Mentor in 1985. Today\, STERIS is a global leader in infection prevention\, contamination control\, surgical and critical care technologies\, and more.  Other top Mentor biomedical companies include Volk Optical\, Frantz Medical Group\, SourceOne Merry X-Ray Corporation\, and Integrated Medical Solutions. \nInternationally recognized clinical research institutions\, including the prestigious Cleveland Clinic\, University Hospitals\, and Case Western Reserve University\, provide Mentor biomedical and med-tech companies a world-class platform for research\, design\, and innovation. \nOhio’s commitment to supporting investment in the biotech industry and these centres of excellence and innovation have driven Ohio’s biomedical industry to grow by 59% since the year 2000\, now employing over 80\,000 experienced workers. \nMentor\, Ohio is strategically located in the heart of this cluster and ready to assist international biomedical and MedTech companies to invest for success. \nOn 5 October 2020\, we are pleased to offer you the opportunity to learn more about the advantages of doing business in Northeast Ohio and the City of Mentor by participating in a virtual conference focused on Ohio’s Medtech innovation corridor. \nConference activities include: \n\nDiscussion with experienced legal advisors on setting up your US business operations and positioning your company for success in the North American market.\nGuidance from high-level US hospital system personnel on the particulars of getting your products and services into the US healthcare system.\nDirect interaction and potential dialogue with US companies and officials that can help you bring your products and services into the United States.\nA company panel talk on doing business in MedTech and BioMed in the US\, featuring TWO Medilink EM Members\, Uvamed and eg Technology.\nMedilink Autumn Networking will be incorporated into the B2B International Networking towards the end of the Conference\, providing an opportunity for both members and non-members to engage with their US counterparts.\n\nFor more information\, contact the Department of Planning and Development at business@cityofmentor.com or visit www.mentormeansbusiness.com. \nTo register for the conference\, click here\nCONFERENCE AGENDA \n8:30 AM EDT / 13.30 BST / 14.30 EST\nWelcome and Presentation\nNortheast Ohio and the City of Mentor – Discovering the competitive advantage for international companies\, particularly in the biomedical and medtech sector\, impacts of COVID-19. \n9:15 AM EDT / 14.15 BST / 15.15 EST\nPresentation\nSetting up your US business operation – things to keep in mind\, effective strategies\, and pitfalls to consider\n     Howard Goulden\, Howard Kennedy\nSteven Howard Roth\, Associate\, Roetzel and Andress \n10:00 AM EDT / 15.00 BST / 16.00 EST      \nBrief Break \n10:10 AM EDT / 15.10 BST / 16.1- EST\nPresentation\nThe Healthcare/BioTech/MedTech Ecosystem in the US/State of Ohio\n       Tyler Allchin\, Director\, Healthcare\, JobsOhio  \n10:35AM EDT / 15.15 BST / 16.15 EST       \nPresentations\nAccessing the business operations of US medical centres\, strategies for success.\n     David Sylvan\, President\, UH Ventures\, University Hospitals\nCleveland Clinic Personnel \n11:15AM EDT / 16.00 BST / 17.00 EST       \nPanel Discussion\nDoing business in biomedical/medtech in the United States\, particularly in a COVID and post-COVID environment\n       Steve Norton\, STERIS Corporation\nJustin Bloyd\, RB Sigma\nKeith Fawdington and Jon Snyder\, UVAMED/Rainbow Trays\nDr. Rouzet Agaiby\, EG Technology \n11:45AM EDT / 16.45 BST / 17.45 EST       \nPresentation\nCleveland Clinic UK Operations from London\n     Travis Laird\, Chief Business Operations Officer \n12:00PM EDT/17.00 BST/18.00 EST\nVirtual B2B Networking\nOpportunity to talk real-time with biomedical and medtech companies from both sides of the Atlantic. \n12:30PM EDT / 17.30 BST / 18.30 EST\nConclusion\nClosing remarks \nTuesday\, 6 October \n9:00AM EDT / 2:00PM BST / 3:00PM EST \nCleveland Clinic Innovation Summit 2020 – Virtual \nTo register for the Cleveland Clinic Summit go to:  https://innovations.clevelandclinic.org/Summit/Overview.aspx
URL:https://www.medilinkmidlands.com/event/mentor-means-business/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/png:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/City-of-Mentor-Seal-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201005T170000
DTEND;TZID=Europe/London:20201005T180000
DTSTAMP:20260403T220448
CREATED:20200403T084137Z
LAST-MODIFIED:20200403T084137Z
UID:18136-1601917200-1601920800@www.medilinkmidlands.com
SUMMARY:Medilink Midlands Virtual Autumn Networking
DESCRIPTION:  \n  \n  \n  \n  \nJoin Medilink Midlands for our virtual Autumn Networking event\, in association with the City of Mentor\, USA. \nNetworking opportunities are one of the many Medilink Midlands member benefits and as the current COVID-19 restricts the opportunity for face to face events\, our Autumn Networking event will now be virtual. \nThis is an informal gathering and will provide an opportunity for both members and non-members to engage with one another as well as their US counterparts. \nBecause of our growing relationship with the City of Mentor\, Ohio\, we have moved our autumn networking to the 5th October\, and it will now be incorporated within the B2B International Networking  at the annual trade mission made by the City of Mentor. The networking will take place towards the end of the conference. As well as the B2B International Networking \, they are hosting an afternoon’s conference. This will provide a chance to learn more about the advantages of doing business in Northeast Ohio and the City of Mentor . \nTo book your place and for further details please click here.\nOpen to both Medilink members and non-members. There is no charge for attending this event. \nPlease note: When booking\, you will be registered for the whole conference\, however you have the option to join at any time\, including just the B2B International Networking opportunity. \nBookings are being managed by The City of Mentor International Trade Initiative\, via Eventbrite. Delegates will receive login credentials and instructions in the week prior to 5 October.
URL:https://www.medilinkmidlands.com/event/autumn-networking/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/potter-clarkson-hires-rgb-logo-colour-scaled.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201008T103000
DTEND;TZID=Europe/London:20201008T113000
DTSTAMP:20260403T220448
CREATED:20200921T111505Z
LAST-MODIFIED:20200921T111505Z
UID:18368-1602153000-1602156600@www.medilinkmidlands.com
SUMMARY:East Midlands Academic Health Science Network Virtual Coffee Break
DESCRIPTION:Join EMAHSN for a virtual coffee break on Thursday 8 October at 10.30am. \nNetworking opportunities are a key part of Medilink EM events and whilst the current COVID-19 crisis still restricts face to face events\, this online opportunity enables the life sciences community to still connect with one another. In this informal gathering\, hosted by Nick Brown\, Commercial Manager at EMAHSN\, you will have the opportunity to share your current challenges and experiences and find out how the EMAHSN can help. \nThe theme for this virtual coffee break will be Patient Public Involvement (PPI)\, Shahnaz Aziz\, PPI and Inclusion Lead from the EMAHSN will be attending to explain the importance of PPI\, how do do it well and the offers the AHSN have to support companies in this activity.  \nGrab a coffee\, a biscuit and join us. \nJoining details will provided to delegates by a member of the Medilink EM events team once the online registration form has been completed. \nIf you have any topics that you’d like to discuss in future AHSN coffee breaks\, please feel free to email any suggestions to us by clicking here. \nChair and Panel details: \n Nick Brown\, Commercial Manager\, EMAHSN \n  \n  \n  \n  \nShahnaz Aziz\, PPI and Inclusion Lead\, EMAHSN \n  \n  \n  \n  \n Aisha Ajij\, Project Support and Industry Liaison Officer\, EMAHSN
URL:https://www.medilinkmidlands.com/event/11088/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Shahnaz-Aziz.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201008T153000
DTEND;TZID=Europe/London:20201008T173000
DTSTAMP:20260403T220448
CREATED:20200916T115752Z
LAST-MODIFIED:20200916T115752Z
UID:18340-1602171000-1602178200@www.medilinkmidlands.com
SUMMARY:Medilink UK Healthcare Virtual Business Awards 2020
DESCRIPTION:Join us for the very first virtual Medilink UK Healthcare Business Awards 2020 and celebrate the very best of UK Life Sciences companies. \nHosted by Chris Turner\, Comedian and Freestyle Rapper\, join us for an afternoon of virtual celebrations\, be entertained and take the opportunity to celebrate with the best of the best in the life sciences sector\, whilst forming new connections with leading professionals on a unique platform of virtual networking. \nThe awards demonstrate that regional depth and national reach by recognising the achievements of the regional Medilink awards winners for 2019-2020 categories; \n– Start Up\, sponsored by HORIBA\n– Export Achievement\, sponsored by Morningside Pharmaceuticals\n– Collaboration with the NHS\, sponsored by the AHSN Network\n– Innovation\, sponsored by Kallik\n– Outstanding Achievement\, sponsored by Mills & Reeve \nMedilink UK are delighted to announce that Grant Thornton are the headline sponsor for these prestigious awards and we are proud to bring you these awards in association with Med-Tech Innovation and MedTech Integrates. \n\nTo read more about our sponsors and the finalists\, please click here. \nNote: These national awards are managed by Medilink East Midlands on behalf of Medilink UK
URL:https://www.medilinkmidlands.com/event/medilink-uk-healthcare-virtual-business-awards-2020/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/MedilinkUK_Logo_1.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201012
DTEND;VALUE=DATE:20201017
DTSTAMP:20260403T220448
CREATED:20200921T122537Z
LAST-MODIFIED:20200921T122537Z
UID:18373-1602460800-1602892799@www.medilinkmidlands.com
SUMMARY:Omnia Health Live: Virtual Trade Missions to Africa & Americas
DESCRIPTION:Join the Department for International Trade (DIT) for Omnia Health Live\, which will provide you with the opportunity to do business remotely and network with healthcare and life sciences professionals from anywhere in the world. \nAbout Omnia Health Live Africa \nThis expo will be the largest virtual healthcare tradeshow of its kind in Africa and will be ideal for companies in the following subsectors: medical devices\, woundcare\, diagnostics (point of care) and infection control. \nAbout Omnia Health Live Americas \nFocused on Latin America\, South America and the southern states of the United States of America (USA)\, this expo will be ideal for companies in the following sub-sectors: medical devices\, surgery and orthopaedics\, maxfac and plastics\, digital health and healthy ageing. \nWhy join? \n•  Be part of a high-profile digital exhibition and conference\n•  Access to overseas buyers and industry leaders\n•  Book meetings with visitors and other exhibitors\n•  Meet prospective buyers via the dedicated app which enables video calling and\nthe sharing of files\n•  Pre-mission briefing and advice\n•  Support from our dedicated healthcare and life sciences sector specialists \n  \nCosts & Funding \nThere is a non-refundable commitment fee of £99 plus VAT\, payable upon final registration. \n  \nHow to register\nSpaces are limited so register your interest today and don’t miss out on this great opportunity to explore the global demand for your products and services. \nFor more detailed information or to register your interest in one (or both) of these virtual trade visit please\nuse the link below. \nClick here to book
URL:https://www.medilinkmidlands.com/event/omnia-health-live-virtual-trade-missions-to-africa-americas/
CATEGORIES:Other Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201013T133000
DTEND;TZID=Europe/London:20201013T143000
DTSTAMP:20260403T220448
CREATED:20200923T153541Z
LAST-MODIFIED:20200923T153541Z
UID:18379-1602595800-1602599400@www.medilinkmidlands.com
SUMMARY:Medilink East Midlands Virtual Coffee Break - Members Only
DESCRIPTION:Join Medilink EM for an afternoon virtual coffee break on Tuesday 13 October at 1.30pm. \nNetworking opportunities are one of the many Medilink EM member benefits and whilst the current COVID-19 crisis still won’t allow face to face events\, we have introduced an online opportunity to enable members to still connect with one another. This is an informal gathering\, hosted by Darren Clark\, our Chief Executive\, where you can share your current challenges and experiences and we can make introductions to those that can help. Or you could also join us just to see a friendly face and take time out from working at home. \nGrab a coffee\, a biscuit and join us. \nDial-in details will provided to delegates by a member of the Medlink EM events team once the online registration form has been completed. \nMedilink Members only \nBook Now
URL:https://www.medilinkmidlands.com/event/medilink-east-midlands-virtual-coffee-break-members-only-3/
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201014T100000
DTEND;TZID=Europe/London:20201014T113000
DTSTAMP:20260403T220448
CREATED:20200213T124632Z
LAST-MODIFIED:20200213T124632Z
UID:18069-1602669600-1602675000@www.medilinkmidlands.com
SUMMARY:WEBINAR: Additive Manufacturing & 3D Printing Special Interest Group (SIG)
DESCRIPTION:The Additive Manufacturing & 3D Printing Special Interest Group (SIG) is back and we have a great online event lined up for you on “Where are we now?”. \nThis event is in partnership with The University of Nottingham – Centre for Additive Manufacturing. The webinar will cover: \n– “Where are we now?”\n– The national additive manufacturing strategy: unleashing the potential in the medtech sector\n– Regulatory considerations for Additive Manufactured Medical Devices \nDURATION: 1.5 hours \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles \n\nRuth Goodridge\, Professor in Additive Manufacturing (3D Printing)\, The University of Nottingham \nRuth is Professor of Additive Manufacturing (3D-Printing) at the University of Nottingham. She is currently on secondment to Nottingham University Hospitals NHS Trust\, based in Clinical Engineering. With a degree in Biomaterials and PhD in Bioengineering\, she has a particular interest in the medical applications of Additive Manufacturing\, including assistive and rehabilitation devices (inc. prosthetics)\, implants and diagnostics. She has 20 years experience in multidisciplinary research into Additive Manufacturing\, including a 2-year JSPS fellowship held at NAIST\, Japan. Her expertise lies in material development for AM and advancing understanding of coupled material-processing aspects\, in particular for polymer and glass powder bed fusion. \n\nPaul Unwin\, Industrial Chair\, Additive Manufacturing Strategy Steering Group (AM UK) \nAM UK is an independent\, government-backed collaboration\, positioned to help drive the UK’s AM strategy. The national strategy published in September 2017 provides recommendations to enable UK industry to unlock the full commercial potential of additive manufacturing and presents the output of 5 years of work undertaken by the UK AM community.\nPreviously\, Paul was the founding CEO of the Stanmore Implants Worldwide Ltd\, who are a world renowned specialist orthopaedic implant service provider. Paul was the creator and architect of a ground-breaking patient-specific implant system that integrated patient imaging\, implant design\, implant manufacture utilising Additive Manufacturing and placing the implants with the aid of robotics\, culminating in the successful surgical placement – a world first. Paul and his team began investigating additive manufacturing for orthopaedic implants in 2006 and after following an extensive development programme built and implanted one of the first additive manufactured mega bone replacements in 2011. \n\nAshley Stratton-Powell\, Senior Medical Device Specialist\, MHRA\nAshley is Technical Lead for Orthopaedics at Medicines and Healthcare products Regulatory Agency (MHRA). He leads a team of Medical Device Specialists who are responsible for investigating trends in adverse incident reports\, issuing patient safety alerts and producing guidance on regulatory issues. He has a PhD in Medical Engineering from the University of Leeds and is a Chartered Engineer with the Institution of Mechanical Engineers.
URL:https://www.medilinkmidlands.com/event/additive-manufacturing-3d-printing-special-interest-group-sig/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Ruth-Goodridge.jpeg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201020T140000
DTEND;TZID=Europe/London:20201020T150000
DTSTAMP:20260403T220448
CREATED:20200930T073818Z
LAST-MODIFIED:20200930T073818Z
UID:18380-1603202400-1603206000@www.medilinkmidlands.com
SUMMARY:WEBINAR: Supply Chain - improving resilience and agility for challenging times
DESCRIPTION:This webinar alongside Mills & Reeve will consider how supply chains are evolving and adapting in these difficult times\, and what you can do to improve your crisis-resilience. \nFor all businesses\, the challenges of the COVID-19 crisis and the forthcoming end of the Brexit transition period present particular difficulties. For life sciences business\, an additional set of considerations arise. With multinational clinical studies\, complex global supply chains and multi-component products a well-planned approach is essential. The COVID-19 pandemic has brought these issues into sharp focus\, as countries battle for scarce supplies of active ingredients\, medicines\, reagents and equipment to enable them to support the effort to combat the outbreak. \nJayne Hussey and Stephanie Caird from Mills & Reeve will cover: \n– How businesses can build supply chain resilience and agility \n– Offer some tips on how to get ahead of a crisis before it happens \n– How some businesses are adopting new ways of working to tackle some of the financial difficulties of disrupted supply chains \n– How to build really effective relationships with your key suppliers \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles:  \n \nStephanie Caird\, Principal Associate\, commercial lawyer specialising in the life sciences sector\, Mills & Reeve\nStephanie is a lawyer specialising in the life sciences practice with experience in intellectual property\, data protection\, commercial contracting and regulatory work. She supports a wide range of clients in the pharma and biotech\, medical devices and diagnostic sectors.\nStephanie has also worked in-house for various life sciences organisations\, giving her a unique insight into her clients. She uses this experience to deliver pragmatic and commercial advice. A key focus of her work is supporting clients on strategic decisions influenced by the regulatory framework and contracts covering IP\, research collaboration and Brexit intra-group arrangements. \n\nJayne Hussey\, Partner\, commercial contracts specialist\, Mills & Reeve\nJayne is a commercial contracts specialist lawyer with a wealth of experience in advising businesses on complex supply chain arrangements\, including outsourcing contracts\, contract manufacturing arrangements and long term supply and purchasing arrangements. Jayne has international contracting expertise and has worked on a significant number of cross-border arrangements.\nJayne is highly regarded by clients for providing straightforward legal advice and support and ensuring that contractual arrangements are structured to deliver objectives. She is trusted by clients to assess proposed contracts in the context of a client’s appetite for risk and its governance framework.
URL:https://www.medilinkmidlands.com/event/webinar-supply-chain-improving-resilience-and-agility-for-challenging-times/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/jayne-hussey.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201021T103000
DTEND;TZID=Europe/London:20201021T113000
DTSTAMP:20260403T220448
CREATED:20200820T075208Z
LAST-MODIFIED:20200820T075208Z
UID:18334-1603276200-1603279800@www.medilinkmidlands.com
SUMMARY:Webinar: Introduction to NHS Market Access
DESCRIPTION:Join our two-part CPD accredited virtual workshop\, Introduction to NHS Market Access\, delivered by the East Midlands Academic Health Science Network (EMAHSN). \nCombined\, the two sessions will give innovators key insights into the complexities of the NHS and wider healthcare ecosystem as well as the support available to help you to introduce your health technology product or service into the NHS. \nPART 1 is a pre-recorded 45 minute webinar that you can watch at a time convenient to you. \nThe webinar will cover: \n– The NHS Structure \n– Understanding pathways and cash flow \n– Getting your message right \n– What support you can expect from the AHSN \n—————— \nPART 2 is a live 1-hour Q&A session that will take place on Wednesday 21st October. \nIn order to gain access to this live session\, delegates are required to watch the pre-recorded webinar prior to attending.  \nThe Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team. \n  \nUpon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink East Midlands events team.  Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.  \nSPEAKER PROFILE:  \nNicholas Brown\, Commercial Manager\, East Midlands Academic Health Science Network \nNick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this\, Nick has more than 20 years’ experience of the medical industry working with manufacturers\, distributors and clinical staff from the UK and European health sectors\, from both the sales and marketing side\, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region – as well as marketed throughout the UK and abroad\, providing wealth creation opportunities across the East Midlands.
URL:https://www.medilinkmidlands.com/event/webinar-introduction-to-nhs-market-access/
ATTACH;FMTTYPE=image/png:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Badge-for-EMAHSN-Webinars.png
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201021T130000
DTEND;TZID=Europe/London:20201021T143000
DTSTAMP:20260403T220448
CREATED:20201019T112546Z
LAST-MODIFIED:20201019T112546Z
UID:18391-1603285200-1603290600@www.medilinkmidlands.com
SUMMARY:MediWales: Finance and Funding Webinar
DESCRIPTION:21st October\, 1pm \nFinal call to register! \nJoin us for the first in our Business Support webinar series\, focusing on finance and funding. \nThis event will highlight sources of grant funding and advice on applications\, as well as fund raising\, pitching and working with investors. \nHear from experts across the sector and first hand company case studies. \nMediWales partners GS Verde will be introducing their new investment platform – Elevate Investment Network. Elevate connects businesses seeking investment\, with a network of experienced business investors. \nYou can find out more about the platform during the webinar\, including how a business seeking investment can apply and also how investors interested in joining the network can register. \nSpeakers include: \n\nVerde Corporate Finance – Craig Blackmore\, Director\nDevelopment Bank of Wales – Richard Thompson\, Senior Investment Executive\nKnowledge Transfer Network – Matt Chapman\, Knowledge Transfer Manager\nCapital Kinetics – Christian Kumar\, Managing Director\nThe Thought Disruptor – Tony Sedgwick\nRescape – Matt Wordley\, CEO\n\nThere will also be time for a panel discussion\, Q&A and virtual networking. \nThis webinar is free to members and £50 + VAT for non members. \nFind out more and register here
URL:https://www.medilinkmidlands.com/event/mediwales-finance-and-funding-webinar/
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201022T103000
DTEND;TZID=Europe/London:20201022T120000
DTSTAMP:20260403T220448
CREATED:20200922T131336Z
LAST-MODIFIED:20200922T131336Z
UID:18375-1603362600-1603368000@www.medilinkmidlands.com
SUMMARY:WEBINAR: The Nottingham Recovery from COVID-19 Research Platform (NoRCoRP) - Developing New Approaches to Treatment
DESCRIPTION:Researchers in Nottingham have launched a new study platform for the next generation of COVID-19 clinical research: The Nottingham Recovery from COVID-19 Research Platform (NoRCoRP). \nThe platform will bring together projects examining the impacts and lasting effects of COVID-19\, translating findings from patients who are known to have contracted the virus into new approaches to treatment to support their recovery. To read about the background on all of the Nottingham Biomedical Research Centre’s COVID-19 research\, click here. \nAttend this webinar to find out about NoRCoRP plus: \n– Background to COVID-19: clinical presentations\, pathophysiology\n– Existing treatment strategies\n– Review of Nottingham portfolio of existing clinical trial and planned clinical studies in patients with COVID-19\n– PHOSP-COVID and NoRCoRP: follow up studies of patients who have had COVID-19\n– Opportunities for engagement with the NIHR Nottingham BRC for COVID related work \nDURATION: 1.5 hours \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profile: \n\nProfessor Ian Hall\, Director\, NIHR Nottingham Biomedical Research Centre \nProfessor Ian is the Director of the NIHR Nottingham\, Biomedical Research Centre. He is a chest physician based at NUH NHS Trust and the University of Nottingham\, and has a long track record of research into the mechanisms underlying the development of a range of lung diseases. He currently chairs the national BRC Director’s forum\, sits on NIHR Strategy Board\, and is a member of UK-CTAP.
URL:https://www.medilinkmidlands.com/event/webinar-the-nottingham-recovery-from-covid-19-research-platform-norcorp-developing-new-approaches-to-treatment/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Ian-Hall-scaled.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201022T140000
DTEND;TZID=Europe/London:20201022T150000
DTSTAMP:20260403T220448
CREATED:20200921T121811Z
LAST-MODIFIED:20200921T121811Z
UID:18372-1603375200-1603378800@www.medilinkmidlands.com
SUMMARY:Accessing the German HealthTech Markets Webinar
DESCRIPTION:In cooperation with Germany Trade & Invest (GTAI) SEHTA would like to invite you to a webinar highlighting market access and opportunities in Germany within the field of digital health. \nDate: Thursday 22nd October 2020 \nTimes: 14:00 – 15:00 (BST) \nCost: Free to attend \nWebinar Platform: WEBEX \n\n \nFor many years\, the digitalization of the German healthcare system was slow on the uptake.  The Covid-19 crisis has given a significant boost to digital health solutions\, which are now seen as an imperative. The pandemic has been a true catalyst for segments such as telemedicine services in Germany. And since the German E-Health Act took effect in January 2016\, a framework has been in place for the integration of information and communication technology within the German healthcare system\, making Germany’s digital health market increasingly attractive. \nThe session will provide insights into Germany’s digital health market\, including the latest market developments\, the legal framework for expanding your business to Germany\, and how GTAI can assist with this process. \nAgenda \n\n\n\nEST Time\nBST Time\nWebinar Programme\n\n\n15:00 – 15:30\n14:00 – 14:30\nMarket Opportunities in Germany – Digital Health \nJulia Pietsch\, Senior Manager of Investor Consulting\, Digital Health\, Germany Trade & Invest (GTAI)\n\n\n15:30 – 15:40\n14:30 – 14:40\nLegal Framework for expanding your business into Germany \nChristina Schön\, Senior Manager of Tax & Legal Services\, Germany Trade & Invest (GTAI) \n \n\n\n15:40 – 16:00\n14:40 – 15:00\nQ&A\n\n\n16:00\n15:00\nClose\n\n\n\nClick here to book
URL:https://www.medilinkmidlands.com/event/accessing-the-german-healthtech-markets-webinar/
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201027T083000
DTEND;TZID=Europe/London:20201027T093000
DTSTAMP:20260403T220448
CREATED:20201012T162833Z
LAST-MODIFIED:20201012T162833Z
UID:18387-1603787400-1603791000@www.medilinkmidlands.com
SUMMARY:Medilink Midlands Virtual Coffee Break - Members Only
DESCRIPTION:Join Medilink Midlands for an early morning virtual coffee break on Tuesday 27 October at 8.30am. \nNetworking opportunities are one of the many Medilink Midlands member benefits and whilst the current COVID-19 crisis still won’t allow face to face events\, we have introduced an online opportunity to enable members to still connect with one another. This is an informal gathering\, hosted by Darren Clark\, our Chief Executive\, where you can share your current challenges and experiences and we can make introductions to those that can help. Or you could also join us just to see a friendly face and take time out from working at home. \nGrab a coffee\, a biscuit and join us. \nDial-in details will provided to delegates by a member of the Medilink EM events team once the online registration form has been completed. \nMedilink Members only \n 
URL:https://www.medilinkmidlands.com/event/medilink-midlands-virtual-coffee-break-6/
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201028
DTEND;VALUE=DATE:20201029
DTSTAMP:20260403T220448
CREATED:20201019T120940Z
LAST-MODIFIED:20201019T120940Z
UID:18393-1603843200-1603929599@www.medilinkmidlands.com
SUMMARY:Making Pharmaceuticals Digital Week: Medilink UK Session
DESCRIPTION:Medilink UK are delighted to be presenting during the Making Pharmaceuticals Digital Week\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nOn Wednesday\, 28 October Dr. Nicola Wall and Dr. Richard Weaver will present a live webinar on behalf of Medilink UK:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nWorking with your CRO: Creating perfect research partnerships in an imperfect research world\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDr. Nicola Wall \nAfortiori Development\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBridging The Gap Between Discovery and Development – DMPK Influence\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDr. Richard Weaver \nXenoGesis Ltd\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nThe webinar is free to attend and will start at 11.00 GMT (12.00 CET | 06.00 EST) \nYou can register to attend using the button below.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRegister for free here\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nView the Full Digital Week Programme Here
URL:https://www.medilinkmidlands.com/event/making-pharmaceuticals-digital-week-medilink-uk-session/
CATEGORIES:Medilink Partner Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/365c5295c6f89d80b6b7d0cabc5af4f0.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201029T110000
DTEND;TZID=Europe/London:20201029T120000
DTSTAMP:20260403T220448
CREATED:20200824T083913Z
LAST-MODIFIED:20200824T083913Z
UID:18337-1603969200-1603972800@www.medilinkmidlands.com
SUMMARY:Webinar: Food Supplements Special Interest Group (SIG)- CBD and the latest developments
DESCRIPTION:Join us online for our next Food Supplements Special Interest Group (SIG) to hear about how\, within the space of a couple of years\, CBD ingestibles have transitioned from a lightly regulated consumer product to potentially being classified as a narcotic and banned from the shelves of retail outlets in Europe. How did this happen and what’s the impact on the CBD industry? \nWe invite you to hear some of the facts around CBD\, providing clarity about its current status and the future challenges and opportunities for companies operating in this sector. All of this will be presented by our speakers\, Janet Worrell\, Head of Regulatory at JensonR+ and Greer Deal\, Director of Global Regulatory Services \nAs well as the opportunity to hear some facts about CBD you can take part in a question and answer session. \nDURATION: 1 Hour \nTO BOOK YOUR PLACE PLEASE CLICK HERE\nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n \nJanet Worrell\, Head of Regulatory\, JensonR+ \nJanet is an experienced regulatory affairs professional\, having supported a diverse portfolio of products\, for a number of companies across the East Midlands. Janet’s experience covers early concept development\, food supplements\, over the counter (OTC) medicines\, inhaled therapies and clinical trial applications. Janet enjoys collaborating with companies to develop their regulatory strategy to deliver commercial success. Janet is an independent board member of the East Midlands Academic Health Science Network supporting innovation within NHS. \n  \nGreer Deal\, Director\, Global Regulatory Services \nGreer has over 25 years’ experience in the life science sector and 13 years ago she co-founded Global Regulatory Services with her husband\, Bobby Deal. One of their first projects involved medicinal cannabis and since then the company has become increasingly involved in plant-derived products whether medicinal\, food or cosmetics. Since January 2019\, Global Regulatory Services has become known as the leading advisers to companies in the cannabis industry with particular expertise in navigating the EU Novel Foods Regulation.
URL:https://www.medilinkmidlands.com/event/webinar-food-supplements-special-interest-group-sig-cbd-and-the-latest-developments/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Greer-Deal.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
END:VCALENDAR